Drugs / Calcitonin
Calcitonin
also known as
Calcitare · Calcitonin, unspecified · Calcitonina · Calcitonine · Calsynar · Miacalcic · salmon calcitonin · Throcalcitonin
Protein / enzyme biologic targets CALCR via activation
Trials 10 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT01292187 | Jan 2011 → May 2012 | osteoporosis | Tarsa Therapeutics, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT00004358 | Nov 1992 → ? | calcinosis | National Center for Research Resources (NCRR) | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT07655804 | Jul 2026 → Apr 2027 expected | herpes zoster | Tanta University | Recruiting | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT03342001 | Jun 2018 → Jun 2019 | hypothyroidism | University of Maryland, Baltimore | Completed | No outcome recorded |
| Phase 4 | NCT00444808 | Feb 2007 → Jan 2008 | — | University of Montreal | Terminated | No outcome recorded |
| Phase not applicable5 trials | ||||||
| — | NCT06330168 | Mar 2024 → May 2025 | — | Tanta University | Completed | No outcome recorded |
| — | NCT05805683 | May 2023 → May 2027 expected | neuropathy, painful, spinal cord injury, thyrocalcitonin secretion disease | Tanta University | Recruiting | No outcome recorded |
| — | NCT00688077 | May 2008 → Dec 2012 | hypophosphatemia | Rijnstate Hospital | Completed | No outcome recorded |
| — | NCT00478335 | May 2007 → Oct 2012 | nephrogenic diabetes insipidus | University of Colorado, Denver | Completed | No outcome recorded |
| — | NCT00114803 | Jan 2004 → Oct 2006 | Crohn disease, ulcerative colitis | Boston Children's Hospital | Completed | No outcome recorded |
Also used as a comparator or background therapy in 5 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT02358304 Comparator | Sep 2007 → Feb 2015 | giant cell reparative granuloma | Shiraz University of Medical Sciences | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00543218 Comparator | Dec 2002 → Jun 2004 | postmenopausal osteoporosis | Eli Lilly and Company | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT04445857 Comparator | Sep 2020 → Jan 2021 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 4 | NCT03935984 Background | May 2019 → Jun 2026 overdue | hypercalcemia disease, primary hyperparathyroidism | Joseph Sferra | Recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02115360 Comparator | Apr 2014 → Aug 2016 | congenital amputation | Tanta University | Completed | No outcome recorded |
Evidence & citations 13 cited values
Every value below carries the sentence it was read from. 16 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Calcitonin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00688077 ↗ |
| Known as | Calcitare | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594242 ↗ |
| Known as | Calcitonin, unspecified | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594242 ↗ |
| Known as | Calcitonina | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594242 ↗ |
| Known as | Calcitonine | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594242 ↗ |
| Known as | Calsynar | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594242 ↗ |
| Known as | Miacalcic | “Calcitonin presented as Miacalcic® ampoules 100 IU/ml (1ml) intrathecally” NCT04445857 ↗ |
| Known as | salmon calcitonin | “patients will receive subcutaneous salmon calcitonin 100 IU (ampoule = 1 ml) daily for three weeks.” NCT07655804 ↗ |
| Known as | Throcalcitonin | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594242 ↗ |
| Action | Activate | “Calcitonin receptor agonist” CHEMBL4594242 ↗ |
| Modality | Protein / enzyme biologic | — CHEMBL4594242 ↗ |
| Route | Subcutaneous | “subcutaneous injections of salmon calcitonin” NCT00004358 ↗ |
| Target | CALCR | “Calcitonin receptor agonist” CHEMBL4594242 ↗ |